{"id":5055,"date":"2023-11-22T15:21:38","date_gmt":"2023-11-22T20:21:38","guid":{"rendered":"https:\/\/inovait.ca\/?p=5055"},"modified":"2023-11-22T15:23:58","modified_gmt":"2023-11-22T20:23:58","slug":"sonic-incytes-is-making-liver-screening-more-accessible","status":"publish","type":"post","link":"https:\/\/inovait.ca\/fr\/sonic-incytes-is-making-liver-screening-more-accessible\/","title":{"rendered":"Sonic Incytes is making liver screening more accessible\u00a0"},"content":{"rendered":"\n[et_pb_section fb_built=”1″ _builder_version=”4.22.2″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” da_disable_devices=”off|off|off” global_colors_info=”{}” theme_builder_area=”post_content” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.23.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#000000″ hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

Non-Alcoholic Fatty Liver Disease across North America<\/span><\/strong><\/h2>\n

Non-alcoholic fatty liver disease is a silent epidemic spreading across North America<\/a>. It\u2019s estimated that 1 in 5 people in Canada have fatty liver disease<\/a>. Over the last few decades, the prevalence of this disease has ballooned globally<\/a> due to dominating sedentary lifestyles and high-fat foods consumed each day, along with other comorbidities that contribute to its progression, including diabetes and obesity. Like with many other life-threatening diseases, early detection and monitoring is crucial to ensuring better treatment outcomes and prognosis.<\/span><\/p>\n

Introduction to Sonic Incytes<\/span><\/strong><\/h3>\n

Sonic Incytes<\/a>, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur\u2122, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia<\/a> (UBC).<\/span><\/p>\n

Current Fatty Liver Disease Screening Options are Leaving Millions Behind<\/span><\/strong><\/h3>\n

Fatty liver disease largely goes undiagnosed due to inaccessible screening options. Today, the only ways you can be screened for fatty liver disease are through invasive biopsies, expensive MRI scans, or limited transient elastography. Liver biopsies are invasive and involve the collection of a small tissue sample which only reveals a fraction of the overall liver health. MRIs are used to measure the fat and elasticity in the liver but are quite costly both in time and money and, in Canada, often have long wait times. The primary screening method for fatty liver disease is transient elastography, but similar to a biopsy, this point-and-shoot system only offers a small viewing window into the overall health of the liver. Not to mention, it has a limited measurement depth and volume sample collected. Since the vast majority of high-risk individuals are overweight or obese, transient elastography is often an ineffective screening method. Lastly, all of these screening methods require immense technical training and expertise. To tackle this growing epidemic, we need a new system to help meet the enormous unmet screening and disease monitoring needs. That\u2019s where Velacur comes into play.<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.23.1″ _module_preset=”default” theme_builder_area=”post_content” column_structure=”1_2,1_2″][et_pb_column _builder_version=”4.23.1″ _module_preset=”default” type=”1_2″ theme_builder_area=”post_content”][et_pb_text _builder_version=”4.23.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#000000″ hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

An Innovative Solution: Velacur<\/span><\/strong><\/h3>\n

Velacur is Sonic Incytes\u2019 innovative, AI-assisted ultrasound that uses S-WAVE technology to accurately and rapidly measure liver stiffness (fibrosis) and attenuation (fat content), key indicators of chronic liver disease. Unlike other non-invasive technologies, Velacur offers superior point-of-care diagnosis, with an easy-to-use interface enabling accurate scans in just 5 minutes, with no sonography experience needed. Additionally, Velacur’s 3D scanning measures 30x more tissue volume with double the depth, ideal for patients with high body fat percentages. <\/span><\/p>[\/et_pb_text][\/et_pb_column][et_pb_column _builder_version=”4.23.1″ _module_preset=”default” type=”1_2″ theme_builder_area=”post_content”][et_pb_image src=”https:\/\/inovait.ca\/wp-content\/uploads\/2022\/10\/VELACUR-RGB-2.png” _builder_version=”4.23.1″ _module_preset=”default” theme_builder_area=”post_content” alt=”Sonic Incytes’ Velacur logo. A purple to light blue gradient made up of polkadots.” title_text=”Velacur” hover_enabled=”0″ sticky_enabled=”0″][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.23.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#000000″ hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

The team at Sonic Incytes has dedicated themselves to ensuring that Velacur is accessible and affordable, to enhance patient care. \u201cWe are passionate about increasing the accessibility of liver screening,\u201d said Barry Allen, CEO at Sonic Incytes. \u201cThrough INOVAIT funding, we have enhanced Velacur to assist users in obtaining high-quality liver scans, regardless of patient body type or clinical expertise.\u201d<\/span><\/p>\n

In 2022, Sonic Incytes was a recipient of the INOVAIT Pilot Fund<\/a>. Shortly thereafter, their progress on Velacur\u2019s enhancements proved incredibly promising, and they were awarded the coveted INOVAIT Focus Fund to further advance Velacur. Since launching their project, Velacur has vastly improved the user experience for healthcare professionals through the release of new FDA cleared AI features, the Organ Guide and Wave Quality Detector. The Organ Guide integrates an in-house developed AI tool that identifies not only the liver but also other organs, tissues, and artifacts in real time. Additionally, it includes a Wave Quality measurement feature that assesses the quantity and quality of shear waves generated and measured by the device, providing superior measurements for people with higher body fat percentages. These crucial enhancements improve the performance of the device to enable less experienced medical personnel to conduct accurate liver scans, with no sonography experience required. The continuous improvement of an innovative medical imaging device requires the united vision of an extremely skilled interdisciplinary team. With INOVAIT\u2019s funding, Sonic Incytes has created and maintained numerous roles within the company to ensure the streamlined growth of Velacur. The skillful team is hard at work further advancing Velacur to improve patient outcomes and help tackle the fatty liver disease epidemic.<\/span><\/p>\n

\u201cToday, reading an ultrasound image requires a lot of skill and training,\u201d said Allen. \u201cBy assisting the user with our advanced features, we can help less experienced users capture fantastic images, ultimately leading to higher quality data. With machine learning assistance, Velacur will lead to increased accuracy of disease progression.\u201d <\/span><\/p>[\/et_pb_text][et_pb_image src=”https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Phases-of-Liver-Disease.png” _builder_version=”4.23.1″ _module_preset=”default” theme_builder_area=”post_content” alt=”The graphic illustrates the different phases of liver disease, identifying the reversible phases from the irreversible ones. ” title_text=”Phases of Liver Disease” hover_enabled=”0″ sticky_enabled=”0″ max_width=”84%” align=”center”][\/et_pb_image][et_pb_text _builder_version=”4.23.1″ _module_preset=”default” theme_builder_area=”post_content” max_width=”90%” text_font_size=”10px” hover_enabled=”0″ sticky_enabled=”0″ module_alignment=”center”]

Figure 1: <\/strong>Fatty liver disease progression is considered to have five phases. The first three phases of liver disease are reversible. Early diagnosis and monitoring are key to reversing liver disease progression.<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.23.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#000000″ hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

The progression of fatty liver disease is often described in five phases (see Figure 1). The first three phases of the disease are reversible with the right lifestyle changes and treatment. As more pharmaceutical treatments become available<\/a> for those suffering from fatty liver disease, it will become even more critical to have a reliable system to evaluate the disease progression of the liver on a more frequent basis. Velacur is poised to fill that gap, providing an easy-to-use, portable, point-of-care device that can assist millions of patients.<\/span><\/p>\n

In summary, fatty liver disease is a growing health concern that affects millions of people in Canada and around the world. The current screening options are either invasive, inaccessible, or lack accuracy, making it difficult to diagnose and regularly monitor the condition. Sonic Incytes, with its Velacur device, has engineered a non-invasive, accurate and accessible liver screening and monitoring device that can help support millions of patients manage their liver disease. With the addition of AI-powered features, this technology that was developed out of a UBC research lab is destined to revolutionize the way liver disease is screened and monitored globally.<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur\u2122, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).<\/p>","protected":false},"author":4,"featured_media":5056,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-5055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-publications"],"acf":[],"yoast_head":"\nSonic Incytes is making liver screening more accessible | INOVAIT<\/title>\n<meta name=\"description\" content=\"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inovait.ca\/fr\/sonic-incytes-is-making-liver-screening-more-accessible\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sonic Incytes is making liver screening more accessible | INOVAIT\" \/>\n<meta property=\"og:description\" content=\"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inovait.ca\/fr\/sonic-incytes-is-making-liver-screening-more-accessible\/\" \/>\n<meta property=\"og:site_name\" content=\"INOVAIT\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-22T20:21:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-22T20:23:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png\" \/>\n\t<meta property=\"og:image:width\" content=\"936\" \/>\n\t<meta property=\"og:image:height\" content=\"738\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ahmed Nasef\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ahmed Nasef\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/\"},\"author\":{\"name\":\"Ahmed Nasef\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/#\\\/schema\\\/person\\\/2e506a897be2b08d7cb93de51832c286\"},\"headline\":\"Sonic Incytes is making liver screening more accessible\u00a0\",\"datePublished\":\"2023-11-22T20:21:38+00:00\",\"dateModified\":\"2023-11-22T20:23:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/\"},\"wordCount\":1425,\"image\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/inovait.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Procedure_Product_13_Resized-min.png\",\"articleSection\":[\"Latest Publications\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/\",\"url\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/\",\"name\":\"Sonic Incytes is making liver screening more accessible | INOVAIT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/inovait.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Procedure_Product_13_Resized-min.png\",\"datePublished\":\"2023-11-22T20:21:38+00:00\",\"dateModified\":\"2023-11-22T20:23:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/#\\\/schema\\\/person\\\/2e506a897be2b08d7cb93de51832c286\"},\"description\":\"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#primaryimage\",\"url\":\"https:\\\/\\\/inovait.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Procedure_Product_13_Resized-min.png\",\"contentUrl\":\"https:\\\/\\\/inovait.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Procedure_Product_13_Resized-min.png\",\"width\":936,\"height\":738,\"caption\":\"A close up of a healthcare professional using the Sonic Incites probe on a patient's stomach to screen for liver disease.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/sonic-incytes-is-making-liver-screening-more-accessible\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/inovait.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sonic Incytes is making liver screening more accessible\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/#website\",\"url\":\"https:\\\/\\\/inovait.ca\\\/\",\"name\":\"INOVAIT\",\"description\":\"INOVAIT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/inovait.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/inovait.ca\\\/#\\\/schema\\\/person\\\/2e506a897be2b08d7cb93de51832c286\",\"name\":\"Ahmed Nasef\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g\",\"caption\":\"Ahmed Nasef\"},\"url\":\"https:\\\/\\\/inovait.ca\\\/fr\\\/author\\\/ahmed-nasefsunnybrook-ca\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sonic Incytes is making liver screening more accessible | INOVAIT","description":"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inovait.ca\/fr\/sonic-incytes-is-making-liver-screening-more-accessible\/","og_locale":"fr_CA","og_type":"article","og_title":"Sonic Incytes is making liver screening more accessible | INOVAIT","og_description":"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.","og_url":"https:\/\/inovait.ca\/fr\/sonic-incytes-is-making-liver-screening-more-accessible\/","og_site_name":"INOVAIT","article_published_time":"2023-11-22T20:21:38+00:00","article_modified_time":"2023-11-22T20:23:58+00:00","og_image":[{"width":936,"height":738,"url":"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png","type":"image\/png"}],"author":"Ahmed Nasef","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ahmed Nasef","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#article","isPartOf":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/"},"author":{"name":"Ahmed Nasef","@id":"https:\/\/inovait.ca\/#\/schema\/person\/2e506a897be2b08d7cb93de51832c286"},"headline":"Sonic Incytes is making liver screening more accessible\u00a0","datePublished":"2023-11-22T20:21:38+00:00","dateModified":"2023-11-22T20:23:58+00:00","mainEntityOfPage":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/"},"wordCount":1425,"image":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#primaryimage"},"thumbnailUrl":"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png","articleSection":["Latest Publications"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/","url":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/","name":"Sonic Incytes is making liver screening more accessible | INOVAIT","isPartOf":{"@id":"https:\/\/inovait.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#primaryimage"},"image":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#primaryimage"},"thumbnailUrl":"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png","datePublished":"2023-11-22T20:21:38+00:00","dateModified":"2023-11-22T20:23:58+00:00","author":{"@id":"https:\/\/inovait.ca\/#\/schema\/person\/2e506a897be2b08d7cb93de51832c286"},"description":"Sonic Incytes, a Canadian AI-assisted medical imaging company is looking to change the way liver disease is screened.","breadcrumb":{"@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#primaryimage","url":"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png","contentUrl":"https:\/\/inovait.ca\/wp-content\/uploads\/2023\/11\/Procedure_Product_13_Resized-min.png","width":936,"height":738,"caption":"A close up of a healthcare professional using the Sonic Incites probe on a patient's stomach to screen for liver disease."},{"@type":"BreadcrumbList","@id":"https:\/\/inovait.ca\/sonic-incytes-is-making-liver-screening-more-accessible\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inovait.ca\/"},{"@type":"ListItem","position":2,"name":"Sonic Incytes is making liver screening more accessible\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/inovait.ca\/#website","url":"https:\/\/inovait.ca\/","name":"INOVAIT","description":"INOVAIT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inovait.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Person","@id":"https:\/\/inovait.ca\/#\/schema\/person\/2e506a897be2b08d7cb93de51832c286","name":"Ahmed Nasef","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6d7970e701d207a3ffa46089e65fe683c61d601767c197567893847f9e103bfd?s=96&d=mm&r=g","caption":"Ahmed Nasef"},"url":"https:\/\/inovait.ca\/fr\/author\/ahmed-nasefsunnybrook-ca\/"}]}},"_links":{"self":[{"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/posts\/5055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/comments?post=5055"}],"version-history":[{"count":0,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/posts\/5055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/media\/5056"}],"wp:attachment":[{"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/media?parent=5055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/categories?post=5055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inovait.ca\/fr\/wp-json\/wp\/v2\/tags?post=5055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}